
1. vaccines (basel). 2019 jun 29;7(3). pii: e57. doi: 10.3390/vaccines7030057.

induction broad polyfunctional hiv-1-specific cell responses the
multiepitopic protein tmep-b vectored mva virus.

perdiguero b(1), sánchez-corzo c(1), sorzano co(2), mediavilla p(1), saiz l(1),
esteban m(3), gómez ce(4).

author information: 
(1)department molecular cellular biology, centro nacional de
biotecnología, consejo superior de investigaciones científicas (cnb-csic), campus
de cantoblanco, 28049 madrid, spain.
(2)biocomputing unit, centro nacional de biotecnología, consejo superior de
investigaciones científicas (cnb-csic), campus de cantoblanco, 28049 madrid,
spain.
(3)department molecular cellular biology, centro nacional de
biotecnología, consejo superior de investigaciones científicas (cnb-csic), campus
de cantoblanco, 28049 madrid, spain. mesteban@cnb.csic.es.
(4)department molecular cellular biology, centro nacional de
biotecnología, consejo superior de investigaciones científicas (cnb-csic), campus
de cantoblanco, 28049 madrid, spain. cegomez@cnb.csic.es.

a human immunodeficiency virus (hiv)/acquired immune deficiency syndrome (aids)
vaccine able induce long-lasting immunity remains major challenge. we
previously designed cell multiepitopic immunogen including protective
conserved epitopes hiv-1 gag, pol nef proteins (tmep-b), induced
potent hiv-1-specific cd8 cells vectored dna combined the
vaccine candidate modified vaccinia virus ankara (mva)-b. here, described 
vectorization tmep-b mva (mva-tmep) evaluated cell immunogenicity
profile elicited mice administered homologous (mva/mva) or
heterologous (dna/mva) prime/boost vector regimens using homologous or
heterologous inserts. heterologous vector regimen superior the
homologous protocol inducing cell responses. dna-tmep-primed animals boosted
with mva-tmep mva-b exhibited highest magnitudes hiv-1-specific cd8,
cd4 follicular helper (tfh) cells, mva-tmep significantly expanding
gag-specific cd8 cell responses. homologous vector regimen, groups
exhibited similar hiv-1-specific cd8 cd4 cell responses, both
mva-b/mva-b mva-tmep/mva-tmep combinations elicited higher gag-pol-nef
(gpn)-specific cd8 cell responses compared mva-tmep/mva-b. results
revealed enhanced induction hiv-1-specific cell responses tmep-b 
vectored dna mva, supported use combined prime/boost
strategies hiv-1 prevention and/or therapy.

doi: 10.3390/vaccines7030057 
pmcid: pmc6789790
pmid: 31261918 

